Observational studyBMC endocrine disorders2026
Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes.
Ilayda Altun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.